Home › Breast Cancer › NCT07655934
A Mixed-Methods Metabolomics Investigation of Lifestyle and Energy Balance During Breast Cancer Survivorship
The MILES Study: A Mixed-Methods Metabolomics Investigation of Lifestyle and Energy Balance During Breast Cancer Survivorship
Who can join
Ages 18 and older · Women
Full eligibility criteria
Inclusion Criteria: * Adult women (age 18 years or older) * Able to read English or Spanish * Newly diagnosed with primary stage 0, I, II, or III breast cancer * Pathological diagnosis within the previous 60 days * Scheduled to have surgery with a Penn Medicine surgeon Exclusion Criteria: * Women age less than 18 years * Women without a new primary breast cancer diagnosis * Women who are pregnant
About the study
The MILES Study is a longitudinal, mixed-methods investigation of urinary biomarkers, energy balance, and lifestyle modifications in diverse women during early breast cancer treatment. The study's overarching goal is to assess dietary quality and physical activity changes over time using reliable, scalable tools suitable for clinical or population settings, supporting newly diagnosed patients in adopting and maintaining healthy behaviors through treatment and survivorship.
What is being tested
- Survey completion (other)
- Urine specimen banking (other)
- Qualitative interviews (other)
Sponsor: Abramson Cancer Center at Penn Medicine · Participants: 100 · Started: Jan 20, 2026
Contact the study team
- Julia Lewandowski · Phone: 215-913-2031
Official record on ClinicalTrials.gov — NCT07655934
Locations in the U.S.
| Pennsylvania | Abamson Cancer Center of the University of Pennsylvania, Philadelphia |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.